ArticleAging cell2026
The Secretome Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Skin Photoaging by Enhancing Mitophagy to Inhibit the cGAS-STING Pathway.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Ultraviolet (UV)-induced skin photoaging is driven by cellular senescence and chronic inflammation. Although the secretome (SCT) derived from human umbilical cord mesenchymal stem cells (hUC-MSC SCT) exhibits regenerative potential, its role in combating photoaging remains to be elucidated. In this study, we show that SCT markedly ameliorates photoaging in UV-exposed mice, restoring epidermal barrier function, dermal collagen integrity, senescence-associated markers, and systemic inflammatory profiles. In UVB-irradiated human immortalized keratinocytes (HaCaT), SCT enhanced cellular viability, proliferation, and migration while alleviating cellular senescence. Mechanistically, SCT promoted mitophagy, as indicated by clearance of mitochondrial proteins (TOM20, TIM23, HSP60), reversal of p62 accumulation, and restoration of LC3B-II flux. By eliminating impaired mitochondria, SCT reduced cytosolic mtDNA leakage, thereby suppressing the overactivation of the cGAS-STING pathway and its downstream pro-inflammatory cytokines IL-6, IL-8, and IFN-β. Importantly, these protective effects were abolished by the mitophagy inhibitor Mdivi-1, whereas the STING inhibitor H151 effectively reversed the Mdivi-1-induced loss of protection, confirming that SCT acts through the hierarchical mitophagy-cGAS-STING axis. Together, our findings establish SCT as a promising cell-free therapeutic strategy for photoaging and highlight the mitophagy-cGAS-STING axis as a critical nexus linking mitochondrial quality control to sterile inflammation in aging tissues.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.